- Social:
Transform
Head of External Affairs at Transform, a British drug reform think-tank
PROFILE
Danny Kushlick
Guest
FROM Danny Kushlick
To the Point
Legal Highs with Lethal Consequences They call them "legal highs" or, in the acronym driven drug lingo, NPS. Novel psychoactive substances are drugs that mimic the highs of banned substances like marijuana or cocaine, but their chemistry has been tinkered with just enough that they fall through the cracks of international drug control laws. Since about 2009 they've been flooding the market, with at times deadly results. Last month, New York, Mississippi and Alabama issued health alerts after a rash of overdoses, and police in Tuscaloosa, Alabama declared a public health crisis when one person died and two dozen were hospitalized after taking an NPS known on the street as "Spice." How can we stop the arms race in legal highs? Would legalization of marijuana and other recreational drugs end up safer for all?
Recommended
To the Point
Janesville and the American Dream Janesville, Wisconsin is the hometown of Republican House Speaker Paul Ryan. But he couldn’t prevent the closing of the General Motors factory after 100 years. On this Memorial Day rebroadcast of To the Point, we hear what’s happened to what once was a model of American middle-class unity.
To the Point
Trump's new look at civil rights and global warming President Trump is reportedly ready to pull the US out of the Paris Agreement on Climate Change. We look at the possible consequences. On the second half of the program, we hear about cuts in Obama-Era civil rights programs called for by the Trump Administration's first budget plan.
To the Point
The Trump agenda: where's the beef? President Trump says big things are happening. After celebrating a House bill on health care, he doesn’t yet have Senate agreement. With James Comey’s public testimony scheduled tomorrow, the President today tweeted his selection of a new FBI Director. Is the Chief Executive all style and no substance? Later, terror attacks in Iran and conflicting claims about who’s behind them.